<DOC>
	<DOCNO>NCT00020267</DOCNO>
	<brief_summary>RATIONALE : Vaccines make peptide may make body build immune response kill tumor cell . PURPOSE : Randomized phase I trial study effectiveness vaccine therapy treat patient metastatic cancer respond previous therapy .</brief_summary>
	<brief_title>Vaccine Therapy Treating Patients With Metastatic Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Determine toxicity profile MAGE-12 peptide vaccine patient refractory metastatic cancer express MAGE-12 antigen . II . Determine whether immunologic response , measure vitro sensitization assay , obtain administration regimen patient . III . Determine frequency administration regimen base immunologic response patient . IV . Determine immunologic parameter patient treat regimen . V. Determine clinical response rate patient treat regimen . PROTOCOL OUTLINE : This randomize study . Patients stratify accord disease ( metastatic cutaneous melanoma v tumor type ) . Patients randomize one two treatment arm . Arm I : Patients receive MAGE-12 peptide vaccine emulsify Montanide ISA-51 adjuvant subcutaneously ( SC ) weekly 4 dos . Arm II : Patients receive MAGE-12 peptide vaccine emulsify Montanide ISA-51 adjuvant SC every 3 week 4 dos . Patients progressive disease may receive interleukin-2 IV 15 minute every 8 hour , begin day immunization continue 4 day . Patients achieve stable disease mixed , partial , complete response continue vaccine therapy alone 24 total dos . Patients follow 3 week . PROJECTED ACCRUAL : A total 26-56 patient ( 13-28 per treatment arm ) accrue study within 1 year .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<mesh_term>Colonic Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Bone Neoplasms</mesh_term>
	<mesh_term>Osteosarcoma</mesh_term>
	<mesh_term>Eye Neoplasms</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Interleukin-2</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Histologically document metastatic cancer one follow type : Cutaneous melanoma Ocular melanoma Colorectal carcinoma Nonsmall cell lung cancer Breast carcinoma Sarcoma HLACw*0702 positive MAGE12 expression RTPCR amplify tissue analysis Failed prior standard therapy Measurable evaluable disease No renal carcinoma Hormone receptor status : Not specify Prior/Concurrent Therapy Biologic therapy : At least 3 week since prior biologic therapy cancer No concurrent biologic therapy cancer Chemotherapy : At least 3 week since prior chemotherapy cancer recover No concurrent chemotherapy cancer Endocrine therapy : At least 3 week since prior hormonal therapy cancer No concurrent hormonal therapy cancer No concurrent steroid Radiotherapy : At least 3 week since prior radiotherapy cancer recover No concurrent radiotherapy cancer Surgery : Prior surgery cancer allow Patient Characteristics Age : 16 Sex : Male female Menopausal status : Not specify Performance status : ECOG 02 Life expectancy : Greater 3 month Hematopoietic : WBC least 3,000/mm3 Platelet count least 90,000/mm3 Hepatic : Bilirubin great 1.6 mg/dL AST/ALT le 3 time normal Renal : Creatinine great 2.0 mg/dL Cardiovascular : No cardiac ischemia , myocardial infarction , cardiac arrhythmia ( receive interleukin2 ( IL2 ) therapy ) Pulmonary : No obstructive restrictive pulmonary disease ( receive IL2 therapy ) Other : Not pregnant Negative pregnancy test Fertile patient must use effective contraception No active systemic infection No autoimmune disease , know immunodeficiency disease , active primary secondary immunodeficiency Hepatitis B surface antigen negative HIV negative No active major medical illness ( receive IL2 therapy )</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2002</verification_date>
	<keyword>Ewing 's family tumor</keyword>
	<keyword>adult soft tissue sarcoma</keyword>
	<keyword>adult solid tumor</keyword>
	<keyword>body system/site cancer</keyword>
	<keyword>bone cancer</keyword>
	<keyword>breast cancer</keyword>
	<keyword>cancer</keyword>
	<keyword>childhood cancer</keyword>
	<keyword>childhood solid tumor</keyword>
	<keyword>ciliary body choroid melanoma , medium/large size</keyword>
	<keyword>colon cancer</keyword>
	<keyword>colorectal cancer</keyword>
	<keyword>extraocular extension melanoma</keyword>
	<keyword>eye cancer</keyword>
	<keyword>female reproductive cancer</keyword>
	<keyword>gastrointestinal cancer</keyword>
	<keyword>genetic condition</keyword>
	<keyword>intraocular melanoma</keyword>
	<keyword>lung cancer</keyword>
	<keyword>male breast cancer</keyword>
	<keyword>melanoma</keyword>
	<keyword>metastatic osteosarcoma</keyword>
	<keyword>metastatic tumor Ewing 's family</keyword>
	<keyword>muscle cancer</keyword>
	<keyword>musculoskeletal cancer</keyword>
	<keyword>non-small cell lung cancer</keyword>
	<keyword>osteosarcoma</keyword>
	<keyword>osteosarcoma/malignant fibrous histiocytoma bone</keyword>
	<keyword>ovarian sarcoma</keyword>
	<keyword>rectal cancer</keyword>
	<keyword>recurrent adult soft tissue sarcoma</keyword>
	<keyword>recurrent breast cancer</keyword>
	<keyword>recurrent colon cancer</keyword>
	<keyword>recurrent intraocular melanoma</keyword>
	<keyword>recurrent melanoma</keyword>
	<keyword>recurrent non-small cell lung cancer</keyword>
	<keyword>recurrent osteosarcoma</keyword>
	<keyword>recurrent rectal cancer</keyword>
	<keyword>recurrent tumor Ewing 's family</keyword>
	<keyword>recurrent uterine sarcoma</keyword>
	<keyword>skin tumor</keyword>
	<keyword>solid tumor</keyword>
	<keyword>stage IIIB , IV , recurrent , metastatic breast cancer</keyword>
	<keyword>stage IV adult soft tissue sarcoma</keyword>
	<keyword>stage IV breast cancer</keyword>
	<keyword>stage IV colon cancer</keyword>
	<keyword>stage IV melanoma</keyword>
	<keyword>stage IV non-small cell lung cancer</keyword>
	<keyword>stage IV rectal cancer</keyword>
	<keyword>stage IV uterine sarcoma</keyword>
	<keyword>stage IVA adult soft tissue sarcoma</keyword>
	<keyword>stage IVB adult soft tissue sarcoma</keyword>
	<keyword>stage , Ewing 's family tumor</keyword>
	<keyword>stage , adult soft tissue sarcoma</keyword>
	<keyword>stage , breast cancer</keyword>
	<keyword>stage , colon cancer</keyword>
	<keyword>stage , intraocular melanoma</keyword>
	<keyword>stage , melanoma</keyword>
	<keyword>stage , non-small cell lung cancer</keyword>
	<keyword>stage , osteosarcoma</keyword>
	<keyword>stage , rectal cancer</keyword>
	<keyword>stage , uterine sarcoma</keyword>
	<keyword>thorax/respiratory cancer</keyword>
	<keyword>uterine sarcoma</keyword>
</DOC>